TORONTO, Nov. 1, 2018 /CNW/ – Enforcer Gold Corp (“Enforcer” or the “Company”) (TSX-V: VEIN – FSE: N071) is pleased to provide its shareholders with further details on the McKenzie Gold project located in the Red Lake Gold Camp of northwestern Ontario. Enforcer announced on October 29, 2018 that it had signed a Letter of Intent (“LOI”) to purchase a 100% interest in the McKenzie Gold property from 1082545 B.C. Ltd.
TORONTO, Oct. 31, 2018 (GLOBE NEWSWIRE) — Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab” or the “Company”) today announced the signing of a non-binding Letter of Intent (the “LOI”) with Labsco Promedic SA de CV of Monterrey, Mexico (“Labsco”) for the establishment of a joint venture relationship for the sales & distribution of Canntab products in Mexico (the “Territory”) on an exclusive basis. Following the LOI, the parties will work together to establish and complete a formal joint venture relationship for an initial period of five years.
TORONTO, Oct. 31, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE: CHV) is pleased to announce the results of the company’s Annual General and Special Meeting of shareholders that was held in Toronto, Ontario on Tuesday, October 30, where a number of business items were presented and approved by the shareholders in attendance.
TORONTO, Oct. 31, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) today announced the launch of a pilot clinical study in Pittsburgh, Pennsylvania, by its strategic R&D partner, SciCann Therapeutics (“SciCann”). The study is designed to test the safety and efficacy of SciCann’s proprietary “Steady Stomach” cannabidiol (CBD) combination product for the treatment of irritable bowel syndrome (IBS) patients. This study follows the previously reported efficacy results from a preclinical study in rodent models which demonstrated a three-fold increased efficacy in lowering abdominal inflammation levels with the advanced combination product as compared to CBD alone.
TORONTO, Oct. 30, 2018 (GLOBE NEWSWIRE) — Snipp Interactive Inc. (“Snipp” or the “Company”) (TSX-V: SPN; OTCPK: SNIPF), a global provider of digital marketing promotions, rebates and loyalty solutions, announces that it held its annual general and special meeting of shareholders (the “Meeting”) on Friday, October 26, 2018.
PORTLAND, Ore., Oct. 30, 2018 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized brands, today announced that it received its cultivation license from the Oregon Liquor Control Commission “OLCC” for its much anticipated Bald Peak facility in Oregon. Construction of the facility is substantially complete, with the build-out of an adjacent shop and nursery scheduled for completion by the end of Q1-2019 and Q2-2019 respectively.
TORONTO, Oct. 29, 2018 /CNW/ – The Board of Directors of FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) is pleased to announce the appointment of Dr. Raza Bokhari as interim CEO and Co-Chairman of the Board of Directors, replacing Thomas Fairfull.
Toronto, Ontario–(Newsfile Corp. – October 26, 2018) – BeWhere (TSXV: BEW) (OTCQB: BEWFF) (“BeWhere” or the “Company”) an Industrial Internet of Things (IIoT) asset tracking solutions provider, and Trak-iT, a leading Canadian provider of tracking solutions under the Fleet Freedom brand, today announced the launch of Canada’s first integrated Mobile-IoT (M-IoT) fleet management solution on Bell’s LTE-M network.
Engagement Labs Inc. announced that it continues to execute on their growth strategy with a major upsell to a leading Fortune 500 US telecom client. The deal represents a significant commitment to Engagement Labs by doubling the contract for the remaining 27 months. The new contract increases the existing agreement by 100 percent, bringing the new contract value to CAD $879,000 (USD $674,325).
TORONTO, Oct. 25, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the Company’s application for a cannabis license under the Excise Tax Act has been conditionally approved by the Canada Revenue Agency (the “CRA”) and is effective as of October 17, 2018. The issuance of a cannabis license by the CRA is a requirement to sell cannabis and is a prerequisite to obtaining a sales license under the Cannabis Act.
